Metabolic disturbances are risk factors for readmission to psychiatric hospitals in non-smokers but not in smokers

Results from a Swiss psychiatric cohort and in first-episode psychosis patients

Datos Bibliográficos

ID15527211
AutoresNermine Laaboub (0000-0001-8029-2418, University of Lausanne), Isabella Locatelli (0000-0003-0870-1461, Centre universitaire de médecine générale et santé publique, Lausanne), Claire Grosu (University of Lausanne), Marianna Piras (University of Lausanne), Tram Ho Ngoc (University of Lausanne), Setareh Ranjbar (0000-0002-0238-2976, University of Lausanne), Martin Preisig (0000-0001-5689-4259, University of Lausanne), Julien Elowe (0000-0002-9538-331X, University of Lausanne), Armin von Gunten (0000-0001-7852-3803, University of Lausanne), Philippe Conus (0000-0002-5832-1910, University of Lausanne), Chin B Eap (0000-0002-5439-0230, University of Geneva, autor de correspondencia)
Año2024
Volumen15
Páginas1256416-1256416
Fecha de publicación2024-02-13
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaFrontiers in Psychiatry (JOURNAL)
Identificadores de la revistaISSN: 1664-0640 • E-ISSN: 1664-0640
EditorialFrontiers Media (PUBLISHER • CH)
DOI10.3389/fpsyt.2024.1256416
PMID38414502
OpenAlexW4391783681
IdiomaEN
Referencias citadas63

The observed interaction between smoking and metabolic variables are compatible with a ceiling effect; metabolic variables increase the risk of readmission in non-smokers but not in smokers who are already at higher risk. Future studies should determine whether better metabolic monitoring and treatment can reduce readmission risk

Body mass index · Cholesterol · Diabetes mellitus · Hypertriglyceridemia · Metabolic syndrome · Obesity · Overweight · Psychiatry · Psychosis · Risk factor · Schizophrenia (object-oriented programming · Triglyceride · Bipolar Disorder and Treatment · Chronic Disease Management Strategies · Medicine · Schizophrenia research and treatment · Endocrinology · Internal Medicine